Literature DB >> 25605891

Population dynamics of islet-infiltrating cells in autoimmune diabetes.

Angela M Magnuson1, Greg M Thurber2, Rainer H Kohler2, Ralph Weissleder2, Diane Mathis3, Christophe Benoist4.   

Abstract

Type-1 diabetes in the nonobese diabetic (NOD) mouse starts with an insulitis stage, wherein a mixed population of leukocytes invades the pancreas, followed by overt diabetes once enough insulin-producing β-cells are destroyed by invading immunocytes. Little is known of the dynamics of lymphocyte movement into the pancreas during disease progression. We used the Kaede transgenic mouse, whose photoconvertible fluorescent reporter permits noninvasive labeling and subsequent tracking of immunocytes, to investigate pancreatic infiltrate dynamics and the requirement for antigen specificity during progression of autoimmune diabetes in the unmanipulated NOD mouse. Our results indicate that the insulitic lesion is very open with constant cell influx and active turnover, predominantly of B and T lymphocytes, but also CD11b(+)c(+) myeloid cells. Both naïve- and memory-phenotype lymphocytes trafficked to the insulitis, but Foxp3(+) regulatory T cells circulated less than their conventional CD4(+) counterparts. Receptor specificity for pancreatic antigens seemed irrelevant for this homing, because similar kinetics were observed in polyclonal and antigen-specific transgenic contexts. This "open" configuration was also observed after reversal of overt diabetes by anti-CD3 treatment. These results portray insulitis as a dynamic lesion at all stages of disease, continuously fed by a mixed influx of immunocytes, and thus susceptible to evolve over time in response to immunologic or environmental influences.

Entities:  

Keywords:  Treg; cell tracer; reporter

Mesh:

Year:  2015        PMID: 25605891      PMCID: PMC4321317          DOI: 10.1073/pnas.1423769112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus.

Authors:  Kevan C Herold; William Hagopian; Julie A Auger; Ena Poumian-Ruiz; Lesley Taylor; David Donaldson; Stephen E Gitelman; David M Harlan; Danlin Xu; Robert A Zivin; Jeffrey A Bluestone
Journal:  N Engl J Med       Date:  2002-05-30       Impact factor: 91.245

Review 2.  T-cell function and migration. Two sides of the same coin.

Authors:  U H von Andrian; C R Mackay
Journal:  N Engl J Med       Date:  2000-10-05       Impact factor: 91.245

3.  An optical marker based on the UV-induced green-to-red photoconversion of a fluorescent protein.

Authors:  Ryoko Ando; Hiroshi Hama; Miki Yamamoto-Hino; Hideaki Mizuno; Atsushi Miyawaki
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

4.  Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunity.

Authors:  A Imagawa; T Hanafusa; S Tamura; M Moriwaki; N Itoh; K Yamamoto; H Iwahashi; K Yamagata; M Waguri; T Nanmo; S Uno; H Nakajima; M Namba; S Kawata; J I Miyagawa; Y Matsuzawa
Journal:  Diabetes       Date:  2001-06       Impact factor: 9.461

5.  Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity.

Authors:  Thomas Stratmann; Natalia Martin-Orozco; Valérie Mallet-Designe; Laurent Poirot; Dorian McGavern; Grigoriy Losyev; Cathleen M Dobbs; Michael B A Oldstone; Kenji Yoshida; Hitoshi Kikutani; Diane Mathis; Christophe Benoist; Kathryn Haskins; Luc Teyton
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

6.  A mouse model for studying intrahepatic islet transplantation.

Authors:  Manami Hara; Dengping Yin; Restituto F Dizon; Jikun Shen; Anita S Chong; Vytas P Bindokas
Journal:  Transplantation       Date:  2004-08-27       Impact factor: 4.939

7.  Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study.

Authors:  A Miyazaki; T Hanafusa; K Yamada; J Miyagawa; H Fujino-Kurihara; H Nakajima; K Nonaka; S Tarui
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

8.  Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient.

Authors:  Urs Christen; Dirk Benke; Tom Wolfe; Evelyn Rodrigo; Antje Rhode; Anna C Hughes; Michael B A Oldstone; Matthias G von Herrath
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

9.  Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells.

Authors:  Alexei Y Savinov; F Susan Wong; Austin C Stonebraker; Alexander V Chervonsky
Journal:  J Exp Med       Date:  2003-03-03       Impact factor: 14.307

10.  Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice.

Authors:  Marie-Claude Gagnerault; Jian Jian Luan; Chantal Lotton; Françoise Lepault
Journal:  J Exp Med       Date:  2002-08-05       Impact factor: 14.307

View more
  39 in total

1.  B lymphocytes protect islet β cells in diabetes prone NOD mice treated with imatinib.

Authors:  Christopher S Wilson; Jason M Spaeth; Jay Karp; Blair T Stocks; Emilee M Hoopes; Roland W Stein; Daniel J Moore
Journal:  JCI Insight       Date:  2019-04-09

Review 2.  The case for an autoimmune aetiology of type 1 diabetes.

Authors:  S I Mannering; V Pathiraja; T W H Kay
Journal:  Clin Exp Immunol       Date:  2015-10-21       Impact factor: 4.330

Review 3.  Immune cell trafficking to the islets during type 1 diabetes.

Authors:  A M Sandor; J Jacobelli; R S Friedman
Journal:  Clin Exp Immunol       Date:  2019-08-30       Impact factor: 4.330

4.  Autoimmune manifestations in aged mice arise from early-life immune dysregulation.

Authors:  Tamer I Mahmoud; Jingya Wang; Jodi L Karnell; Qiming Wang; Shu Wang; Brian Naiman; Phillip Gross; Philip Z Brohawn; Chris Morehouse; Jordan Aoyama; Clive Wasserfall; Laura Carter; Mark A Atkinson; David V Serreze; Helen Braley-Mullen; Tomas Mustelin; Roland Kolbeck; Ronald Herbst; Rachel Ettinger
Journal:  Sci Transl Med       Date:  2016-10-19       Impact factor: 17.956

5.  SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions.

Authors:  Ferdinando Pucci; Christopher Garris; Charles P Lai; Andita Newton; Christina Pfirschke; Camilla Engblom; David Alvarez; Melissa Sprachman; Charles Evavold; Angela Magnuson; Ulrich H von Andrian; Katharina Glatz; Xandra O Breakefield; Thorsten R Mempel; Ralph Weissleder; Mikael J Pittet
Journal:  Science       Date:  2016-03-17       Impact factor: 47.728

6.  Imaging the emergence and natural progression of spontaneous autoimmune diabetes.

Authors:  James F Mohan; Rainer H Kohler; Jonathan A Hill; Ralph Weissleder; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-24       Impact factor: 11.205

7.  Activation of the Aryl Hydrocarbon Receptor by 10-Cl-BBQ Prevents Insulitis and Effector T Cell Development Independently of Foxp3+ Regulatory T Cells in Nonobese Diabetic Mice.

Authors:  Allison K Ehrlich; Jamie M Pennington; Xisheng Wang; Diana Rohlman; Sumit Punj; Christiane V Löhr; Matthew T Newman; Siva K Kolluri; Nancy I Kerkvliet
Journal:  J Immunol       Date:  2015-11-16       Impact factor: 5.422

Review 8.  Type 1 diabetes genetic susceptibility and dendritic cell function: potential targets for treatment.

Authors:  Chie Hotta-Iwamura; Kristin V Tarbell
Journal:  J Leukoc Biol       Date:  2016-01-20       Impact factor: 4.962

Review 9.  CAR T cells for infection, autoimmunity and allotransplantation.

Authors:  Colby R Maldini; Gavin I Ellis; James L Riley
Journal:  Nat Rev Immunol       Date:  2018-10       Impact factor: 53.106

10.  Brief exposure to hyperglycemia activates dendritic cells in vitro and in vivo.

Authors:  Aline M Thomas; Ying Dong; Nicholas M Beskid; Andrés J García; Andrew B Adams; Julia E Babensee
Journal:  J Cell Physiol       Date:  2019-11-01       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.